RE: Yet just a month a go1 Sep 2024 09:03
Thank you bigh. Nail on the head. I have far more here this than I should. Likewise HE1 who have just rinsed pis for a third time in 18 months with dilution at another massive discount. It’s always the management of these companies that does the damage and is why once/if I get out of these stocks I’m currently in (also CPX, KOD) with out too great a loss I will stay off AIM in future. I wish I had put all I had into RR two years ago when they changed CEO. It’s gone from 70p a share to 500p. Instead I put just £50k in there and left it. Others like IMB, LL and MSTR have all done incredibly well for me. With AIM there is the chance to make huge gains very quickly indeed but the MO for the vast majority of the Directors is to look after themselves first and share holders last. Start up companies and developing companies are on AIM because they need funding. Lots of it. I understand that. However, it seems they are all intent on being as economical with the truth as they can be at all times because things are hardly ever truly rosy. Huge dilutions for iis to make a quick Buck and continue their salaries hurt the pis most and I’m sick of it. Some are outright frauds and actually have nothing, the very worst being EUA which has just lied to the market for years and is now on the verge of going under imo.
I have never denigrated GDR’s products or the R and D side of their business but how, just how can any self respecting businessman run a company with such massive costs and no income, dilute its shareholders whilst asking them to rescue it, and still refuse to be honest about sales projections or answer an editable question about the possibility of the company going private?? No, this is all fair play in the AIM book. Par for the course. My thoughts on the company do swing per wildly but that’s because of the wild changes in its prospects. 6 weeks ago they were looking great. Imo we’re now starting to see just how badly the BODs have assessed the need for these tests. On paper yes, they make a lot of sense and would save the NHS amounts of money. In reality the NHS is in a critical state financially and simply don’t have the funds to purchase all the machines needed to do the genomic testing even just on MT-RNR1, never mind CYP2C19. I firmly believe if the NHS has bought it for hospitals nationwide then many foreign territories would have followed suit. This hasn’t yet happened. Manchester have bought it very quickly. Why not ask the others. Cheek showed his frustration and gave the game away imo when he posted that X msg asking why were London hospitals not buying. They’ve obviously been aware of the tests, been shown the machines but chosen not to buy/use them. Why else would he post that msg?? If they were negotiating or talking or even considering buying then he would have kept silent. He didn’t and so since then, again imo, I think the company’s prospects have nosedived.
I am now hugely frustrated and angry with t